OSSFF Income Statement - TTM - Embla Medical hf.

Income Statement (TTM)

Embla Medical hf. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	639	630	637	692	701	719	728	719	715	719	730	750	766	786	804	820	840	855	858	874
Change (%)		-1.55	1.15	8.71	1.23	2.56	1.28	-1.24	-0.50	0.48	1.55	2.80	2.16	2.51	2.37	1.91	2.51	1.74	0.34	1.83
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	245	238	239	252	257	263	270	271	271	279	283	288	293	300	310	313	319	320	316	326
Change (%)		-2.59	0.21	5.50	1.83	2.64	2.74	0.12	0.03	2.95	1.33	1.97	1.84	2.26	3.42	0.90	1.92	0.32	-1.37	3.08
% of Revenue	38.25	37.85	37.50	36.39	36.61	36.63	37.16	37.68	37.87	38.81	38.72	38.41	38.29	38.20	38.59	38.20	37.98	37.45	36.81	37.27

Gross Operating Profit	395	391	398	440	444	455	457	448	444	440	447	462	473	486	494	507	521	535	542	548
Change (%)		-0.91	1.73	10.63	0.88	2.52	0.44	-2.05	-0.82	-1.04	1.69	3.32	2.36	2.67	1.73	2.55	2.88	2.60	1.37	1.10
% of Revenue	61.75	62.15	62.50	63.61	63.39	63.37	62.84	62.32	62.13	61.19	61.28	61.59	61.71	61.80	61.41	61.80	62.02	62.55	63.19	62.73

SG&A	303	307	308	318	323	328	331	331	339	339	345	354	353	360	368	371	375	380	380	384
Change (%)		1.22	0.29	3.38	1.41	1.64	0.76	0.10	2.39	-0.06	1.85	2.58	-0.22	1.99	2.16	0.82	1.16	1.35	-0.02	1.16
% of Revenue	47.43	48.76	48.35	45.98	46.06	45.64	45.41	46.03	47.36	47.11	47.25	47.15	46.05	45.82	45.72	45.23	44.63	44.46	44.30	44.01

R&D	30	31	31	31	32	32	34	33	34	34	34	36	37	38	38	39	40	41	42	43
Change (%)		2.92	-0.49	2.03	0.89	-0.12	6.34	-1.30	0.75	1.39	1.33	5.22	1.71	3.38	0.30	2.79	1.56	2.24	1.77	3.30
% of Revenue	4.71	4.93	4.85	4.55	4.53	4.42	4.64	4.63	4.69	4.73	4.72	4.84	4.81	4.85	4.76	4.80	4.75	4.78	4.84	4.91

OpEx	578	576	577	602	611	623	635	635	643	652	662	678	683	698	716	723	734	741	737	753
Change (%)		-0.31	0.22	4.18	1.56	1.97	1.88	0.03	1.30	1.29	1.60	2.46	0.76	2.18	2.60	0.96	1.51	0.95	-0.51	2.10
% of Revenue	90.39	91.54	90.69	86.92	87.20	86.69	87.21	88.34	89.93	90.66	90.70	90.40	89.16	88.87	89.06	88.23	87.37	86.69	85.96	86.19

Operating Income	61	53	59	91	90	96	93	84	72	67	68	72	83	87	88	96	106	114	120	121
Change (%)		-13.29	11.26	52.79	-0.96	6.63	-2.63	-9.95	-14.11	-6.77	1.12	6.09	15.38	5.24	0.57	9.67	10.02	7.18	5.87	0.16
% of Revenue	9.61	8.46	9.31	13.08	12.80	13.31	12.79	11.66	10.07	9.34	9.30	9.60	10.84	11.13	10.94	11.77	12.63	13.31	14.04	13.81

Interest Expense	-9	-10	-10	-11	-11	-10	-10	-9	-10	-11	-13	-17	-18	-18	-20	-19	-21	-23	-22	-21
Change (%)		3.61	3.84	9.12	-0.99	-9.13	-2.32	-8.25	8.44	17.66	15.08	29.79	6.14	1.10	8.81	-1.76	10.75	9.35	-3.31	-6.12
% of Revenue	-1.45	-1.53	-1.57	-1.57	-1.54	-1.36	-1.31	-1.22	-1.33	-1.56	-1.77	-2.23	-2.32	-2.29	-2.43	-2.34	-2.53	-2.72	-2.62	-2.42

Net Income	20	6	11	48	50	64	62	57	47	43	43	45	52	58	57	61	69	68	72	73
Change (%)		-68.58	72.11	344.35	4.90	28.37	-3.70	-7.28	-17.44	-9.88	2.26	3.90	15.79	11.64	-2.50	7.32	13.04	-1.14	5.71	1.33
% of Revenue	3.09	0.99	1.68	6.87	7.11	8.90	8.47	7.95	6.60	5.92	5.96	6.02	6.82	7.43	7.08	7.45	8.22	7.99	8.41	8.37

Source: Capital IQ

DK:EMBLA	DKK31.90
GB:EMBLAC
DE:5IQ
GB:0FIW

Embla Medical hf. - Income Statement (TTM)

Income Statement (TTM)

Other Listings